JNJ News 101.93 06/18/2014 05:08:12 Johnson & Johnson (JNJ)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Johnson & Johnson (JNJ) 101.93 $JNJ

Final Glance: Medical Devices companies
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

J&J's Velcade in Focus at the European Hematology Association - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 4:20PM CDT
Johnson & Johnson (JNJ) presented encouraging data from a phase III study on its oncology drug, Velcade, at the annual meeting of the European Hematology Association.

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
PR Newswire - Tue Jun 17, 4:00PM CDT
Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 15th, to review second-quarter results. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dominic Caruso, Vice President, Finance and Chief Financial Officer; Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman, Pharmaceuticals; Joaquin Duato, Worldwide Chairman, Pharmaceuticals; and Louise Mehrotra, Vice President, Investor Relations, will host the call.

Drugs Drive Growth For Johnson & Johnson
at Investor's Business Daily - Tue Jun 17, 3:58PM CDT
At 128 years old, Johnson & Johnson (JNJ) is still delivering growth and income for its shareholders. It's not Band-Aid bandages and baby oil that's driving growth for the New Brunswick, N.J.-based health-care giant. Out of its three operating units,...

Beck Expands Team With Experienced Director of Operations
PRWeb - Tue Jun 17, 3:04PM CDT
Beck, a print reproduction process authority specialized in enhancing a brand's image on the shelf or any media output, has expanded its executive leadership team with the addition of Jimmy Watkins as Director of Operations. Mr. Watkins brings more than 20 years of design and packaging commercialization expertise, and will be responsible for identifying and implementing process improvements to optimize a brand's color consistency and printed image.

ExxonMobil, Johnson & Johnson Tumble as Dow Gains
Dan Carroll, The Motley Fool - Motley Fool - Tue Jun 17, 1:39PM CDT
The market has struggled to stay on course today, and the Dow Jones Industrial Average  beat back earlier losses to rise 35 points into the green as of 2:35 p.m. EDT. Twelve  of the blue-chip index's 30 member stocks were in the red. ExxonMobil ...

3-D Printing Company Materialise Prices IPO and Is Expected to Begin Trading on June 24
Beth McKenna, The Motley Fool - Motley Fool - Tue Jun 17, 1:03PM CDT
The 3-D printing stocks have taken a bruising in 2014, but that's not stopping Belgium-based Materialise from throwing its hat into the publicly traded ring. IPO terms were released last week, so we can now explore these questions: Does this...

Midday Glance: Medical Devices companies
AP - Tue Jun 17, 12:27PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:

Midday Glance: Pharmaceuticals companies
AP - Tue Jun 17, 12:27PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:

Johnson & Johnson (JNJ) Crosses Pivot Point Support at $101.90
Comtex SmarTrend(R) - Tue Jun 17, 11:42AM CDT
Johnson & Johnson (NYSE:JNJ) has opened bearishly below the pivot of $102.39 today and has reached the first level of support at $101.90. Should the shares continue to fall, the support pivots of $101.34 and $100.29 will be of interest.

Early Glance: Medical Devices companies
AP - Tue Jun 17, 9:39AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:

Early Glance: Pharmaceuticals companies
AP - Tue Jun 17, 9:39AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

Global Autism Clinical Trials Review 2014
M2 - Tue Jun 17, 9:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vhfbw6/autism_global) has announced the addition of the "Autism Global Clinical Trials Review, H1, 2014" report to their offering. Autism Global Clinical Trials Review, H1, 2014 provides data on the Autism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Autism. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Espy the commercial landscape of the major Universities / Institutes / Hospitals & Companies - Autism Speaks, Inc. - Seaside Therapeutics, LLC - Forest Laboratories, Inc. - Johnson & Johnson - Otsuka Holdings Co., Ltd. - F. Hoffmann-La Roche Ltd. - Bristol-Myers Squibb Company - Coronado Biosciences, Inc. - ZonMw - Dainippon Sumitomo Pharma Co., Ltd. - National Institute of Mental Health - Massachusetts General Hospital - Tehran University of Medical Sciences - Eunice Kennedy Shriver National Institute of Child Health and Human Development - Hugo W. Moser Research Institute at Kennedy Krieger, Inc. - Stanford University - The University of Hong Kong - University of California, Los Angeles - Mount Sinai Hospital - University of California, San Francisco For more information visit http://www.researchandmarkets.com/research/vh...ism_global

RF Micro Devices, Select Income Reality, TriQuint Semi, Medtronic,Covidien, Johnson & Johnson, iShares U.S. Medical Devices ETF, Pfizer and AstraZeneca highlighted as Zacks Bull and Bear of the Day
PR Newswire - Tue Jun 17, 8:30AM CDT
Zacks Equity Research highlights RF Micro Devices (Nasdaq:RFMD-Free Report) as the Bull of the Day and Select Income Reality (NYSE:SIR-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onTriQuint Semi (Nasdaq:TQNT-Free Report), Medtronic (NYSE:MDT-Free Report), Covidien (NYSE:COV-Free Report), Johnson & Johnson (NYSE:JNJ-Free Report), iShares U.S. Medical Devices ETF (AMEX:IHI-Free Report), Pfizer (NYSE FE-Free Report) and AstraZeneca (NYSE:AZN-Free Report).

Better Stock Today Challenge: Johnson & Johnson vs. DistributionNow
David Williamson and Joel South, The Motley Fool - Motley Fool - Mon Jun 16, 3:20PM CDT
In the spirit of World Cup competition, we're holding our own tournament in search of the Better Stock Today. We're pitting 32 companies against each other and you, the reader, will determine the winner. Johnson & Johnson  takes on ...

Will Medtronic's Deal for Covidien Push Stryker to Smith & Nephew?
at The Street - Mon Jun 16, 12:32PM CDT
For Stryker, this deal would be accretive within the first full year of completion, generating immediately value for shareholders of both companies.

Medtronic's Acquisition Isn't Just About Lowering Its Tax Bill
at The Street - Mon Jun 16, 12:27PM CDT
There's more to its buying competitor Covidien for $42.9 billion.

Medtronic Buying Covidien, Becoming Device Colossus
at Investor's Business Daily - Mon Jun 16, 9:33AM CDT
Shares of medical device maker Covidien (COV) jumped 28% to above 92 on the stock market today after Medtronic (MDT) announced late Sunday that it is buying the company for $43 billion. Medtronic's cash-and-stock payment amounts to $93.22 a share,...

Johnson & Johnson Scores a Solid Hit With Imbruvica
Cheryl Swanson, The Motley Fool - Motley Fool - Mon Jun 16, 8:30AM CDT
The biggest cancer conference of the year is over, and star talent Imbruvica one out of the ballpark for its Big Pharma part-owner, Johnson & Johnson . Shares of Johnson & Johnson outperformed the S&P 500 since the beginning of the...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mace Consult Bets on Sawaya for Americas Expansion

Updated Category News Views 151

Concrete, tunnel bores, and data-center campuses rarely wait politely for a leadership transition. Mace Consult has named Mario Sawaya president of its Americas business, and the hire reads less like ceremonial executive shuffling than a deliberate move toward the thickest part of the capital-spending map. Sawaya brings more than 20 years of experience leading...

Continue Reading
Saban Center Partnership Gives Health Learning a Lift

Updated Category News Views 45

A dinosaur race may sound like pure kid bait, but the underlying idea is sturdier than that. Cardiac Solutions and the Seale family are backing an interactive health-and-performance exhibit at Tuscaloosa’s planned Saban Center, a project intended to turn questions about movement, fitness, heart rate and oxygen levels into something children can actually touch, test and...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 72

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 30

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 140

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 63

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Dario's WebMD Deal Opens a Vast, Unproven Channel Path

Updated Category News Views 141

One partnership can look like a gold mine from across the valley; getting the ore out is another matter entirely. DarioHealth has struck a strategic partnership with WebMD Health Services that could put its multi-condition care platform in front of an enormous commercial ecosystem: more than 3,500 employers and 65 million covered lives. That is a meaningful distribution...

Continue Reading
DJI Puts 3D Conservation Tools to Work Across Segovia

Updated Category News Views 146

Stone monuments do not care about marketing slogans; they care whether somebody notices the crack before winter gets hold of it. That is why DJI’s World Heritage 3D Conservation Initiative in Segovia lands as more than a shiny drone-company ceremony. The company gathered winning 3D fly-through work from its first initiative, but the useful bit was the case for turning...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 55

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 70

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Spectral Capital Reaches Key Patent Goals in Quantum Technology

Updated Category News Views 129

Major Developments at Spectral Capital Spectral Capital Corporation (OTCQB: FCCN), a visionary company in quantum technology, is excited to announce a significant achievement in its ongoing pursuit to lead the quantum computing domain through a robust patent strategy. Achieving Patent Milestones Recently, the company shared that it has successfully filed 104 provisional...

Continue Reading
Nexalin Technology Successfully Raises $5 Million in Offering

Updated Category News Views 219

Nexalin Technology Successfully Completes $5 Million Offering Nexalin Technology, Inc. (NASDAQ: NXL; NXLIW) has recently announced the successful closing of its underwritten public offering, which involved the sale of 3,850,000 shares of common stock at a price of $1.30 per share. This offering garnered close to $5 million in gross proceeds for the company, reflecting a...

Continue Reading
Louis Hernandez Jr. Launches 'Digital Tsunami' Enhancing Tech

Updated Category News Views 522

A New Chapter in Technology with 'Digital Tsunami' In a thrilling development for the tech industry, Louis Hernandez Jr. has unveiled his latest book, 'Digital Tsunami.' This publication serves as a clarion call for change, urging both industry leaders and consumers to prepare for a wave of innovative advancements. As technology rapidly evolves, Hernandez emphasizes the...

Continue Reading
Insights from Booking Holdings at the Citi Global TMT Conference

Updated Category News Views 141

Exciting Presentation by Booking Holdings at Citi Conference Booking Holdings (NASDAQ: BKNG) is set to take the stage at the Citi 2025 Global TMT Conference, an exciting event for technology, media, and telecom industries. The event will feature the insightful Chief Financial Officer, Ewout Steenbergen, who will engage in an enriching fireside chat. Details of the...

Continue Reading
Bluevine Reports Small Business Optimism and Growth Ahead

Updated Category News Views 291

Small Business Confidence on the Rise Bluevine's recent survey sheds light on the optimism radiating from small business owners (SBOs) despite ongoing economic challenges. Their 2024 End-of-Year Business Owner Success Survey, commonly referred to as the BOSS Report, reveals a significant trend: SBOs are developing strategies to thrive even amidst uncertainty. Insights...

Continue Reading